Join us for the 7th Annual diaTribe Musings Panel Discussions
Upcoming Event: Wednesday, December 7, 2022
5:30-6:45pm EST / 2:30-3:45pm PST
Heart disease is one of the main causes of death in people with diabetes, and diabetes is one of the leading causes of kidney failure. The good news is that we now have better tools and strategies to keep your heart, blood vessels, and kidneys healthy while living with diabetes. These include lifestyle changes and medications that can significantly lower your risk of developing these complications — or slow their progression.
With a focus on therapies for people with T2D, this panel will give you the information you need to know to keep your heart and kidneys healthy. Our panel of experts will include two endocrinologists at the center of making new preventative therapies available, a renowned cardiologist and researcher who specializes in keeping people with diabetes healthy, and a person living with diabetes who has survived both a heart attack and diabetic kidney disease.
Panel discussion with Q&A from 5:30-6:45pm EST / 2:30-3:45pm PST, with Community Networking and Expo Booths open beginning 15 minutes prior. Community Networking and Expo Booths will also remain open following the panel.
Mikhail Kosiborod, MD, FACC, FAHA
Cardiologist | Executive Director, Cardiometabolic Center Alliance | Vice President for Research, Saint Luke's Health System
Dr. Mikhail Kosiborod is a cardiologist, the Vice President of Research at Saint Luke’s Health System, Executive Director of the Cardiometabolic Center Alliance, Director of Cardiometabolic Research and Co-Director of the Haverty Cardiometabolic Center of Excellence at Saint Luke’s Mid America Heart Institute, Professor of Medicine at the University of Missouri-Kansas City, and the inaugural recipient of the Ben McCallister, MD Endowed Chair in Cardiovascular Research at Saint Luke’s Health System. Dr. Kosiborod received training in clinical research, epidemiology, and health policy through the Robert Wood Johnson Clinical Scholars Program, as well as clinical training in cardiovascular medicine at Yale University School of Medicine. Dr. Kosiborod is an internationally recognized expert in cardiometabolic medicine. Dr. Kosiborod has authored and co-authored over 300 peer-reviewed publications, including scientific statements and position documents. Dr. Kosiborod is involved in the leadership of multiple clinical trials and multi-center registries.
Leo Seman, MD, PhD
Medical Expert, Cardio-Metabolism, US Clinical Development and Medical Affairs at Boehringer Ingelheim Pharmaceuticals
Dr. Seman plays a critical role at Boehringer Ingelheim (USA) in delivering scientific presentations to US payors, and since 2016, he has been responsible for much of the scientific input into the clinical development and medical affairs projects within the company’s metabolism program. From 2011 to 2016, Dr. Seman was Director of Clinical Development and Medical Affairs, responsible for the Jardiance Medical plan. Prior to that, he served as global medical lead for the development of Empagliflozin (Jardiance), implementing the clinical development of Phases 1 to 3, including early regulatory interactions. Prior to joining Boehringer Ingelheim, Dr. Seman was the Global Clinical Lead at Bayer Pharmaceuticals for the development of several products within the metabolism and cardiology portfolios. Dr. Seman was previously an assistant professor of medicine and a Scientist II at Tufts University and the Jean Mayer, USDA, Human Nutrition Research Center, respectively. Dr. Seman completed his residency in Internal Medicine at the Wake-Forrest Medical Center in Winston-Salem, NC, and his fellowships in endocrinology and nutrition at Tufts University. Dr. Seman graduated from Dalhousie University in Halifax, Nova Scotia, Canada with an M.D. and a Ph.D. in Biochemistry, focused on lipid metabolism.
Senior Medical Director (Field Physician), Medical Affairs CVMD, at AstraZeneca
Dr. Suren Sivarajah completed his undergraduate studies at Bucknell University in Lewisburg, PA where he graduated magna cum laude. He went on to earn his medical degree from Penn State College of Medicine in Hershey, PA, where he also completed his internal medicine residency and a fellowship in endocrinology, diabetes, and metabolism. Prior to joining AstraZeneca, Dr. Sivarajah served as the Diabetes Director at Penn State College of Medicine. In this role, he provided oversight on all diabetes-related clinical and scholarly activity, with a focus on delivering optimal integrated diabetes treatment across the spectrum of inpatient and outpatient care. Dr. Sivarajah also worked with medical students, residents, and fellows to improve diabetes education and scholarly activity. One of Dr. Sivarajah's passions is teaching medical students, medical residents, nurses, pharmacists, and advanced practitioners. He has been published in numerous peer reviewed journals. Dr. Sivarajah has received numerous teaching awards including being awarded the Teacher of the Year Award at Reading Hospital and Medical Center. He is an active member of Endocrine Society and the American Diabetes Association.
Anne Safran Dalin
Patient Advocate | Member, National Kidney Foundation Advocacy Committee
Founder of DiabetesMine | Diabetes Innovation Advocate and Journalist
Amy is a journalist, blogger and nationally known patient advocate who hosts her own series of thought leadership events (the annual DiabetesMine Innovation Days and biannual DiabetesMine D-Data ExChange) that bring patient entrepreneurs together with the medical establishment to accelerate change. Amy was Founder and Editor-in-Chief of DiabetesMine.com, a leading online information destination for people with diabetes that she launched after her diagnosis with Type 1 diabetes in 2003. From 2015-2022, DiabetesMine was part of San Francisco-based Healthline Media, where Amy also served as Editorial Director, Diabetes & Patient Advocacy. Amy was one of the early pioneers in the Diabetes Online Community (DOC), and has conducted numerous patient community research projects that have appeared in peer-reviewed journals, including the Journal of Diabetes Science and Technology. She serves as an advisor to the ADCES (Association of Diabetes Care and Education Specialists). Amy holds an MA in Communication Studies from UC Santa Barbara. She is a well-known public speaker at national diabetes, healthcare, and health technology events. When not working, she enjoys hiking, cooking, aerobic workouts, and just about anything fun done under California sunshine.
About diaTribe Musings
Previously known as Musings Under the Moon, when it was a single live event at the ADA Scientific Sessions, diaTribe Musings is now one of The diaTribe Foundation's most treasured ongoing virtual programs, engaging a diverse audience in thought-provoking dialogue and providing an opportunity to connect healthcare providers, business leaders, people living with diabetes, advocates, families, entrepreneurs, and policymakers. Musings tickets are complimentary thanks to the generous support of our sponsors. We welcome anyone interested in learning about the massive shifts and opportunities occurring in the world of diabetes. Please spread the word and share this event with anyone interested in learning more about diabetes. Join the conversation on Twitter with #diaTribeMusings.
Past Musings Events